logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Carboplatin/nivolumab/pembrolizumabParaneoplastic neurologic syndromes presenting as encephalitis and sensory neuronopathy: 3 case reports

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2019年 / 1761卷 / 1期
关键词:
D O I:
10.1007/s40278-019-64473-2
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:101 / 101
相关论文
共 50 条
  • [31] Ipilimumab/nivolumab/pembrolizumabMyocarditis: 3 case reports
    Reactions Weekly, 2022, 1909 (1) : 303 - 303
  • [32] Nivolumab/pembrolizumabPancreatitis and sarcoidosis : 3 case reports
    Reactions Weekly, 2018, 1704 (1) : 284 - 284
  • [33] Ipilimumab/nivolumab/pembrolizumabThyroiditis: 3 case reports
    Reactions Weekly, 2019, 1748 (1) : 268 - 268
  • [34] Carboplatin/PaclitaxelHypersensitivity reactions: 3 case reports
    Reactions Weekly, 2024, 2025 (1) : 114 - 114
  • [35] Carboplatin/cisplatin/paclitaxelNeutropenia: 3 case reports
    Reactions Weekly, 2020, 1806 (1) : 74 - 74
  • [36] Carboplatin/paclitaxelMultiple toxicities: 3 case reports
    Reactions Weekly, 2015, 1542 (1) : 69 - 69
  • [37] Carboplatin/cisplatinHearing loss: 3 case reports
    Reactions Weekly, 2011, 1343 (1) : 11 - 11
  • [38] Carboplatin/paclitaxelNo response: 3 case reports
    Reactions Weekly, 2022, 1931 (1) : 169 - 169
  • [39] Carboplatin/cisplatin/etoposideNeutropenia: 3 case reports
    Reactions Weekly, 2020, 1800 (1) : 92 - 92
  • [40] Carboplatin/etoposide/ifosfamideThrombocytopenia: 3 case reports
    Reactions Weekly, 2019, 1776 (1) : 113 - 113
← 12345 →